Van Nostrand Robert L's Form 4 filing
Intra-Cellular Therapies, Inc. (ITCI) · filed Feb 28, 2024
- Accession no.
- 0000950170-24-022485
- Filed
- Feb 28, 2024
- Trade date
- Feb 27, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.46M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Van Nostrand Robert LCIK 0001225198 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2024 | Common Stock | MOption exerciseAcquired | +20,000 | $18.56 | +$371,200 | 29,611 | Direct | |
| Feb 27, 2024 | Common Stock | SSaleDisposed | −9,651 | $72.71 | −$701,724.21 | 19,960 | Direct | |
| Feb 27, 2024 | Common Stock | SSaleDisposed | −10,349 | $73.14 | −$756,925.86 | 9,611 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2024 | Common Stock | MOption exerciseDisposed | −20,000 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.